NATIONAL BUREAU OF ECONOMIC RESEARCH
NATIONAL BUREAU OF ECONOMIC RESEARCH

Innovation Policy and the Economy Working Group


2015
w21105 Roland Bénabou
Davide Ticchi
Andrea Vindigni

Forbidden Fruits: The Political Economy of Science, Religion, and Growth

w21090 Alexander Galetovic
Stephen Haber
Ross Levine

An Empirical Examination of Patent Hold-up

w21012 Michael Kremer
Christopher Snyder

Preventives Versus Treatments

w20995 María José Abud Sittler
Bronwyn Hall
Christian Helmers

An Empirical Analysis of Primary and Secondary Pharmaceutical Patents in Chile

w20969 Richard G. Newell
Juha V. Siikamaki

Individual Time Preferences and Energy Efficiency

w20954 Jorge Guzman
Scott Stern

Nowcasting and Placecasting Entrepreneurial Quality and Performance

w20922 Mikko Packalen
Jay Bhattacharya

New Ideas in Invention

w20921 Mikko Packalen
Jay Bhattacharya

Cities and Ideas

w20920 Mikko Packalen
Jay Bhattacharya

Age and the Trying Out of New Ideas

w20902 Ashish Arora
Sharon Belenzon
Andrea Patacconi

Killing the Golden Goose? The Decline of Science in Corporate R&D

w20889 Pierre Azoulay
Joshua S. Graff Zivin
Danielle Li
Bhaven N. Sampat

Public R&D Investments and Private-sector Patenting: Evidence from NIH Funding Rules

w20878 Leila Agha
David Molitor

The Local Influence of Pioneer Investigators on Technology Adoption: Evidence from New Cancer Drugs

w20867 David H. Howard
Peter B. Bach
Ernst R. Berndt
Rena M. Conti

Pricing in the Market for Anticancer Drugs

w20854 B. Zorina Khan
Invisible Women: Entrepreneurship, Innovation and Family Firms in France during Early Industrialization

w20846 Mu-Jeung Yang
Lorenz Kueng
Bryan Hong

Business Strategy and the Management of Firms


2014
w20743 Daron Acemoglu
Ufuk Akcigit
Douglas Hanley
William Kerr

Transition to Clean Technology

w20732 B. Zorina Khan
Of Time and Space: Technological Spillovers among Patents and Unpatented Innovations during Early U.S. Industrialization

w20731 B. Zorina Khan
Inventing in the Shadow of the Patent System: Evidence from 19th-Century Patents and Prizes for Technological Innovations

w20683 Julia Lane
Jason Owen-Smith
Rebecca Rosen
Bruce Weinberg

New Linked Data on Research Investments: Scientific Workforce, Productivity, and Public Value

w20676 William R. Kerr
Ramana Nanda

Financing Innovation

w20670 Joseph E. Stiglitz
Unemployment and Innovation

w20668 Kirk Doran
Alexander Gelber
Adam Isen

The Effects of High-Skilled Immigration on Firms: Evidence from H-1B Visa Lotteries

w20621 Lorenz Kueng
Mu-Jeung Yang
Bryan Hong

Sources of Firm Life-Cycle Dynamics: Differentiating Size vs. Age Effects

w20615 Ajay Agrawal
Carlos Rosell
Timothy S. Simcoe

Do Tax Credits Affect R&D Expenditures by Small Firms? Evidence from Canada

w20587 Yael V. Hochberg
Carlos J. Serrano
Rosemarie H. Ziedonis

Patent Collateral, Investor Commitment, and the Market for Venture Lending

w20548 Mark Duggan
Craig Garthwaite
Aparajita Goyal

The Market Impacts of Pharmaceutical Product Patents in Developing Countries: Evidence from India

w20532 Lee Branstetter
Chirantan Chatterjee
Matthew J. Higgins

Starving (or Fattening) the Golden Goose?: Generic Entry and the Incentives for Early-Stage Pharmaceutical Innovation

w20521 Richard B. Freeman
Immigration, International Collaboration, and Innovation: Science and Technology Policy in the Global Economy

w20379 John Komlos
Has Creative Destruction Become More Destructive?

w20375 Mercedes Delgado
Michael E. Porter
Scott Stern

Defining Clusters of Related Industries

w20367 Gerald Carlino
William R. Kerr

Agglomeration and Innovation

w20364 Joshua S. Gans
Remix Rights and Negotiations Over the Use of Copy-Protected Works

w20358 William R. Kerr
Ramana Nanda
Matthew Rhodes-Kropf

Entrepreneurship as Experimentation

w20292 Keith M. Drake
Martha A. Starr
Thomas McGuire

Do "Reverse Payment" Settlements of Brand-Generic Patent Disputes in the Pharmaceutical Industry Constitute an Anticompetitive Pay for Delay?

w20269 Alberto Galasso
Mark Schankerman

Patents and Cumulative Innovation: Causal Evidence from the Courts

w20212 David Dranove
Craig Garthwaite
Manuel Hermosilla

Pharmaceutical Profits and the Social Value of Innovation

w20102 Nicholas Bloom
Renata Lemos
Raffaella Sadun
Daniela Scur
John Van Reenen

The New Empirical Economics of Management

w20069 Sari Pekkala Kerr
William R. Kerr
William F. Lincoln

Firms and the Economics of Skilled Immigration

w20039 Hezekiah Agwara
Philip Auerswald
Brian Higginbotham

Algorithms and the Changing Frontier

w20037 Annamaria Conti
Christopher C. Liu

The (Changing) Knowledge Production Function: Evidence from the MIT Department of Biology for 1970-2000

w20036 Chris Forman
Avi Goldfarb
Shane Greenstein

Information Technology and the Distribution of Inventive Activity

w20016 Rena M. Conti
Ernst R. Berndt

Specialty drug prices and utilization after loss of U.S. patent exclusivity, 2001-2007

w20012 Ajay K. Agrawal
John McHale
Alex Oettl

Why Stars Matter

w19962 Petra Moser
Alessandra Voena
Fabian Waldinger

German-Jewish Emigres and U.S. Invention

w19951 Nicholas Bloom
Paul M. Romer
Stephen J. Terry
John Van Reenen

Trapped Factors and China's Impact on Global Growth

w19894 Daron Acemoglu
Ufuk Akcigit
Murat Alp Celik

Young, Restless and Creative: Openness to Disruption and Creative Innovations

w19868 Ejaz Ghani
William R. Kerr
Stephen D. O'Connell

Political Reservations and Women's Entrepreneurship in India

w19866 Benjamin Jones
E.J. Reedy
Bruce A. Weinberg

Age and Scientific Genius

w19819 Richard B. Freeman
Ina Ganguli
Raviv Murciano-Goroff

Why and Wherefore of Increased Scientific Collaboration


Generated Mon Apr 27 00:00:22 2015

 
Publications
Activities
Meetings
NBER Videos
Data
People
About

Support
National Bureau of Economic Research, 1050 Massachusetts Ave., Cambridge, MA 02138; 617-868-3900; email: info@nber.org

Contact Us